Benjamin Layno

Array ( [id] => 3721539 [patent_doc_number] => 05700466 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Method of ameliorating or preventing septic shock using a monoclonal antibody specific to cachectin/tumor necrosis factor' [patent_app_type] => 1 [patent_app_number] => 8/348764 [patent_app_country] => US [patent_app_date] => 1994-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3724 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700466.pdf [firstpage_image] =>[orig_patent_app_number] => 348764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3700400 [patent_doc_number] => 05674719 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Method for producing monoclonal antibodies specific to hair follicles' [patent_app_type] => 1 [patent_app_number] => 8/339262 [patent_app_country] => US [patent_app_date] => 1994-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 2784 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674719.pdf [firstpage_image] =>[orig_patent_app_number] => 339262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781207 [patent_doc_number] => 05840302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Treatment of bacterially-induced inflammatory diseases' [patent_app_type] => 1 [patent_app_number] => 8/337614 [patent_app_country] => US [patent_app_date] => 1994-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12061 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840302.pdf [firstpage_image] =>[orig_patent_app_number] => 337614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3734383 [patent_doc_number] => 05753229 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Monoclonal antibodies reactive with tumor proliferating cells' [patent_app_type] => 1 [patent_app_number] => 8/335573 [patent_app_country] => US [patent_app_date] => 1994-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 15530 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753229.pdf [firstpage_image] =>[orig_patent_app_number] => 335573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3806710 [patent_doc_number] => 05811249 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Control of infectious microorganisms by modulation of chorionic gonadotropin-related protein activity' [patent_app_type] => 1 [patent_app_number] => 8/327362 [patent_app_country] => US [patent_app_date] => 1994-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 7603 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811249.pdf [firstpage_image] =>[orig_patent_app_number] => 327362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686054 [patent_doc_number] => 05643759 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Method for preparing bispecific monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/327254 [patent_app_country] => US [patent_app_date] => 1994-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 4282 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643759.pdf [firstpage_image] =>[orig_patent_app_number] => 327254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781176 [patent_doc_number] => 05840301 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors' [patent_app_type] => 1 [patent_app_number] => 8/326552 [patent_app_country] => US [patent_app_date] => 1994-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 9711 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840301.pdf [firstpage_image] =>[orig_patent_app_number] => 326552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624502 [patent_doc_number] => 05620889 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Human anti-Fas IgG1 monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/322805 [patent_app_country] => US [patent_app_date] => 1994-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 15283 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/620/05620889.pdf [firstpage_image] =>[orig_patent_app_number] => 322805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874033 [patent_doc_number] => 05747294 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Compositions and methods for the prevention and diagnosis of lyme disease' [patent_app_type] => 1 [patent_app_number] => 8/320161 [patent_app_country] => US [patent_app_date] => 1994-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20682 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747294.pdf [firstpage_image] =>[orig_patent_app_number] => 320161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619188 [patent_doc_number] => 05688657 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/304524 [patent_app_country] => US [patent_app_date] => 1994-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15786 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688657.pdf [firstpage_image] =>[orig_patent_app_number] => 304524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3549692 [patent_doc_number] => 05518721 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-21 [patent_title] => 'Antibodies against Streptococcus' [patent_app_type] => 1 [patent_app_number] => 8/301481 [patent_app_country] => US [patent_app_date] => 1994-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3181 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/518/05518721.pdf [firstpage_image] =>[orig_patent_app_number] => 301481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3748244 [patent_doc_number] => 05717071 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Cross-protective human monoclonal antibody compositions' [patent_app_type] => 1 [patent_app_number] => 8/300118 [patent_app_country] => US [patent_app_date] => 1994-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20305 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/717/05717071.pdf [firstpage_image] =>[orig_patent_app_number] => 300118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3837289 [patent_doc_number] => 05707621 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Supression of nephritis-induced protein excretion by anti-IL-8' [patent_app_type] => 1 [patent_app_number] => 8/299156 [patent_app_country] => US [patent_app_date] => 1994-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 4760 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/707/05707621.pdf [firstpage_image] =>[orig_patent_app_number] => 299156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3514167 [patent_doc_number] => 05505945 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-09 [patent_title] => 'Method and compositions for the direct concentrated delivery of passive immunity' [patent_app_type] => 1 [patent_app_number] => 8/295482 [patent_app_country] => US [patent_app_date] => 1994-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6587 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 294 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/505/05505945.pdf [firstpage_image] =>[orig_patent_app_number] => 295482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3610968 [patent_doc_number] => 05565337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'Hybridoma-producing NSO myeloma cell line' [patent_app_type] => 1 [patent_app_number] => 8/294416 [patent_app_country] => US [patent_app_date] => 1994-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3179 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565337.pdf [firstpage_image] =>[orig_patent_app_number] => 294416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646605 [patent_doc_number] => 05629197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Monoclonal anti-human breast cancer antibodies' [patent_app_type] => 1 [patent_app_number] => 8/288981 [patent_app_country] => US [patent_app_date] => 1994-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8406 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629197.pdf [firstpage_image] =>[orig_patent_app_number] => 288981 [rel_patent_id] =>[rel_patent_doc_number] =>)